Main competitors
Capi.($) Investor ESG MSCI Fundamentals Financial revisions Global Valuation Visibility Consensus
17.18B
A
51.85B
A
44.26B
AAA
30.83B -
A
- -
26.6B - - - -
19.48B - - - -
18.8B
AAA
17.28B
B
-
15.07B -
AA
- -
12.09B -
B
- -
11.33B
BB
10.75B -
9.8B - -
9.7B -
BB
- -
8.92B -
BBB
- -
8.51B -
CCC
- -
8.15B -
AA
- -
8.47B -
CCC
- -
7.77B
AA
6.51B - - - -
Average 17.17B
A
Weighted average by Cap.
A
Bio Therapeutic Drugs